ONCOPEPTIDES AB NPV revenue breakdown overview

ONCOPEPTIDES AB NPV revenue for the last year amounted to 36.59 M SEK, the most of which — 35.22 M SEK — came from its highest performing source at the moment, Pharmaceutical Drugs, the year earlier bringing 8.36 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought ONCOPEPTIDES AB NPV 24.33 M SEK, and the year before that — 7.79 M SEK.